Peptide fragments of hiv

Details Peptide fragments of hiv Peptide fragments of hiv

C - Chemistry, Metallurgy

07

K

C07K 7/08 (2006.01) A61K 35/18 (2006.01) A61K 39/21 (2006.01) C07K 14/16 (2006.01) G01N 33/569 (2006.01) A61K 39/00 (2006.01)

Patent

CA 2064691

2064691 9101996 PCTABS00003 A peptide is described which has the amino acid sequence of a fragment of HIV which interacts specifically with a particular human leucocyte antigen (HLA) class I molecule, to stimulate cytotoxic T lymphocyte immunity. Such a fragment can be used in a potential vaccine against AIDS (acquired immune deficiency syndrome), and for diagnostic and therapeutic purposes. The peptide has the sequence NH2-asparagine-proline-proline-isoleucine-proline-valine-glycine-glutamate-is_ oleucine-tyrosine-lysine-arginine-tryptophan-isoleucine-isoleucine-(cysteine)x_ -COOH, where x is 0 or 1.

Affiliated with

Also associated with

Rating

Peptide fragments of hiv does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Peptide fragments of hiv, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide fragments of hiv will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1793235